Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
AIDS Malignancy Consortium
AIDS Malignancy Consortium
University of Louisville
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)